Opportunity
SAM #6912710440008
VA award for emergency Pluvicto and Lutathera radiopharmaceuticals
Buyer
VA 262 Network Contract Office 22
Posted
October 29, 2026
Identifier
6912710440008
NAICS
325412, 424210
The Department of Veterans Affairs awarded a one-month emergency bridge order for cancer-treatment radiopharmaceuticals at VA Greater Los Angeles Healthcare System. - Government buyer - Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Network Contracting Office 22. - Award and supplier - Award amount: $769,496.80. - OEM and supplier: Novartis Pharmaceuticals Corporation, identified as the only authorized source listed in the VA NAC catalog. - Products requested - Pluvicto — radiopharmaceutical radioligand therapy for cancer; quantity and part number not stated. - Lutathera — radiopharmaceutical radioligand therapy for cancer; quantity and part number not stated. - Notable requirements - The one-month bridge order is intended to maintain continuity of cancer care while the longer-term FY 2027 order is finalized. - The justification cites urgent patient-care needs and the proprietary, specialized nature of the medications. - Per-injection prices are not provided.